4//SEC Filing
Conatus Pharmaceuticals Inc. 4
Accession 0001209191-16-096375
CIK 0001383701operating
Filed
Feb 7, 7:00 PM ET
Accepted
Feb 8, 4:20 PM ET
Size
8.3 KB
Accession
0001209191-16-096375
Insider Transaction Report
Form 4
Hagerty David T
EVP, Clinical Development
Transactions
- Award
Stock Option (Right to Buy)
2016-02-04+109,375→ 109,375 totalExercise: $1.85Exp: 2026-02-03→ Common Stock (109,375 underlying) - Award
Stock Option (Right to Buy)
2016-02-04+21,875→ 21,875 totalExercise: $1.85Exp: 2026-02-03→ Common Stock (21,875 underlying)
Footnotes (2)
- [F1]The option was granted on February 4, 2016. 25% of the total number of shares of common stock subject to the option will vest on February 4, 2017, and 1/48th of the total number of shares of common stock subject to the option will vest monthly thereafter, subject to the Reporting Person's continued employment or service relationship with the Issuer on each such vesting date.
- [F2]The Reporting Person was granted a performance based option on February 4, 2016 that will vest, subject to the Reporting Person's continued employment or service relationship with the Issuer through the applicable vesting date, upon the achievement of certain performance conditions, as approved by the Issuer's compensation committee.
Documents
Issuer
Conatus Pharmaceuticals Inc.
CIK 0001383701
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001383701
Filing Metadata
- Form type
- 4
- Filed
- Feb 7, 7:00 PM ET
- Accepted
- Feb 8, 4:20 PM ET
- Size
- 8.3 KB